MK-677 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of MK-677 is approximately 24 hours. This means dosing once daily (usually before bed) is typical to maintain stable levels. The half-life directly affects how long MK-677 remains active and influences optimal injection timing.
What Is the Half-Life of MK-677?
The half-life of MK-677 is approximately 24 hours. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer MK-677 to maintain therapeutic blood levels.
What Does MK-677's Half-Life Mean for Dosing?
With a half-life of approximately 24 hours, MK-677 requires dosing once daily (usually before bed) to maintain stable levels. The standard dosage of 10-25 mg daily via oral accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, MK-677 reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For MK-677, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject MK-677?
Optimal timing depends on your research goals. A half-life of approximately 24 hours means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily (usually before bed)) for more stable levels throughout the day.
How Does MK-677's Half-Life Compare to Similar Peptides?
MK-677 is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue. Its half-life of approximately 24 hours positions it with a shorter duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your MK-677 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MK-677.
Open Calculator →Bottom Line: MK-677 Half-Life and Dosing
MK-677 has a half-life of approximately 24 hours, supporting the standard protocol of 10-25 mg daily dosed once daily (usually before bed) over 8-16 weeks; minimum 10-week break between cycles.
Read our MK-677 dosage guide for complete protocol details.
Complete Guide
MK-677 (Ibutamoren): The Oral GH Secretagogue
Related Reading
- MK-677 Dosage Guide
- MK-677 Benefits
- MK-677 Side Effects
- MK-677 Stacking Guide
- MK-677 Cycle Guide
- MK-677 Research
Research-Grade Sourcing
If you're going to research MK-677, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MK-677?
MK-677 (Ibutamoren Mesylate) is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue. Synthetic non-peptide compound developed by Merck as an oral GH secretagogue alternative to injectable GHRPs. It is researched for oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
What is the recommended MK-677 dosage?
Common dosages: 10-25 mg daily administered once daily (usually before bed) via oral. Cycle length: 8-16 weeks; minimum 10-week break between cycles. Half-life: approximately 24 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of MK-677?
Increased appetite (primary side effect), water retention, lethargy, joint pain, elevated prolactin. Insulin resistance with long-term use — monitor fasting glucose. Carpal tunnel syndrome reported at higher doses. Generally well-tolerated but requires metabolic monitoring.
Is MK-677 safe?
MK-677 has shown a favorable safety profile in research. Not FDA-approved. Not a controlled substance but banned by WADA and DoD. Sold as research chemical. All research should follow appropriate safety protocols.